310 related articles for article (PubMed ID: 7883986)
1. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.
Gilkeson GS; Pippen AM; Pisetsky DS
J Clin Invest; 1995 Mar; 95(3):1398-402. PubMed ID: 7883986
[TBL] [Abstract][Full Text] [Related]
2. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA.
Gilkeson GS; Ruiz P; Pippen AM; Alexander AL; Lefkowith JB; Pisetsky DS
J Exp Med; 1996 Apr; 183(4):1389-97. PubMed ID: 8666897
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
[TBL] [Abstract][Full Text] [Related]
4. Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA.
Wloch MK; Alexander AL; Pippen AM; Pisetsky DS; Gilkeson GS
J Immunol; 1997 May; 158(9):4500-6. PubMed ID: 9127017
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
6. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice.
Gilkeson GS; Conover J; Halpern M; Pisetsky DS; Feagin A; Klinman DM
J Immunol; 1998 Oct; 161(8):3890-5. PubMed ID: 9780154
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
8. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus.
Tucker RM; Roark CL; Santiago-Raber ML; Izui S; Kotzin BL
Arthritis Rheum; 2004 Nov; 50(11):3626-36. PubMed ID: 15529369
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
10. Genetic association between natural autoantibody responses to histones and DNA in murine lupus.
Tokushige K; Kinoshita K; Hirose S; Shirai T
Autoimmunity; 1992; 12(4):285-93. PubMed ID: 1391598
[TBL] [Abstract][Full Text] [Related]
11. Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB X NZW)F1 hybrid.
Kohno A; Yoshida H; Sekita K; Maruyama N; Ozaki S; Hirose S; Shirai T
Immunogenetics; 1983; 18(5):513-24. PubMed ID: 6642573
[TBL] [Abstract][Full Text] [Related]
12. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice.
Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP
Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573
[TBL] [Abstract][Full Text] [Related]
13. Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide.
Riemekasten G; Kawald A; Weiss C; Meine A; Marell J; Klein R; Hocher B; Meisel C; Hausdorf G; Manz R; Kamradt T; Burmester GR; Hiepe F
Arthritis Rheum; 2001 Oct; 44(10):2435-45. PubMed ID: 11665986
[TBL] [Abstract][Full Text] [Related]
14. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
[TBL] [Abstract][Full Text] [Related]
15. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
[TBL] [Abstract][Full Text] [Related]
16. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
17. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
18. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
19. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
